Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Phase II prospective trial.
about
Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Phase II prospective trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Combination gemcitabine/cispla ...... a Phase II prospective trial.
@en
type
label
Combination gemcitabine/cispla ...... a Phase II prospective trial.
@en
prefLabel
Combination gemcitabine/cispla ...... a Phase II prospective trial.
@en
P2093
P2860
P356
P1476
Combination gemcitabine/cispla ...... f a Phase II prospective trial
@en
P2093
Bassel El-Rayes
Cecilia G Ethun
Charles A Staley
David A Kooby
Edith Brutcher
Juan M Sarmiento
Lauren M Postlewait
Shishir K Maithel
Zhengjia Chen
P2860
P304
P356
10.1002/JSO.24317
P50
P577
2016-08-08T00:00:00Z